Synapse - Works

Results (4925)

Enasidenib (AG-221) in mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML): Results of a phase 1 dose-escalation and expansion study

Meeting Abstract

Stein, E. M.; DiNardo, C. D.; Pollyea, D. A.; Fathi, A. T.; Roboz, G. J.; Altman, J. K.; Stone, R. M.; Flinn, I. W.; Kantarjian, H. M.; Collins, R.; more...
Haematologica (2017)

Fulltext@MSK | Save

CheckMate 227: A randomized, open-label phase 3 trial of nivolumab, nivolumab plus ipilimumab, or nivolumab plus chemotherapy versus chemotherapy in hemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC)

Meeting Abstract

Paz-Ares, L.; Brahmer, J.; Hellmann, M. D.; Reck, M.; O'Byrne, K.; Borghaei, H.; Geese, W. J.; Lu, H.; Nathan, F. E.; Ramalingam, S.
Annals of Oncology (2017)

Fulltext@MSK | Save

Atezolizumab as first-line (1L) therapy for advanced non-small cell lung cancer (NSCLC) in PD-L1-selected patients: Efficacy data from the BIRCH trial

Meeting Abstract

Peters, S.; Costa, E. C.; Garassino, M. C.; Christoph, D.; Kurata, T.; Chaft, J.; Johnson, M. L.; Mocci, S.; Gettinger, S. N.; Felip, E.
Annals of Oncology (2017)

Fulltext@MSK | Save

Patients with light chain amyloidosis treated with NEOD001 achieve rapid organ responses that are independent of previous plasma cell-directed therapies

Meeting Abstract

Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
Haematologica (2017)

Fulltext@MSK | Save

Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far

Meeting Abstract

Smit, E.; Soria, J. C.; Janjigian, Y. Y.; Groen, H. J. M.; Pao, W.; Calvo, E.; Gazzah, A.; Fan, J.; Ould-Kaci, M.; Horn, L.
Annals of Oncology (2017)

Fulltext@MSK | Save

Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia

Meeting Abstract

Ravandi, F.; Stein, A.; Erba, H.; Lancet, J.; Stein, E.; Faderl, S.; Walter, R.; Advani, A.; DeAngelo, D.; Kovacsovics, T.; more...
Haematologica (2017)

Fulltext@MSK | Save

Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL

Meeting Abstract

Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Santomasso, B.; Sadelain, M.; Brentjens, R.
Haematologica (2017)

Fulltext@MSK | Save

Identification of aberrantly spliced genes and deregulated pathways/gene ontology themes in myelodysplastic syndrome patients with splicing factor gene mutations

Meeting Abstract

Pellagatti, A.; Steeples, V.; Sharma, E.; Repapi, E.; Radujkovic, A.; Horn, P.; Armstrong, R. N.; Dolatshad, H.; Roy, S.; Lockstone, H.; more...
Haematologica (2017)

Fulltext@MSK | Save

A novel vascular targeted photodynamic therapy (VTP) in orthotopic rat model for the treatment of esophageal cancer

Meeting Abstract

Ronny, U.; Dina, P.; Lilach, A.; Rachel, E.; David, K.; Hans, G.; Jonathan, C.; Katie, M.; Varda, B.; Keren, S.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)

Meeting Abstract

Argilés, G.; Saro, J.; Segal, N. H.; Melero, I.; Ros, W.; Marabelle, A.; Rodriguez, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save